Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FtAl8cIZOfaTGBjnX43BoTyLaqP4.uncropped.jpg&w=3840&q=75)
Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check4 days agoNo Change Detected
- Check5 days agoChange DetectedThe study has expanded to include 172 locations and has been updated from revision v2.9.7 to v2.10.0.SummaryDifference0.1%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check14 days agoChange DetectedDifference0.2%
- Check17 days agoChange DetectedDifference0.2%
- Check18 days agoChange DetectedDifference0.2%
- Check24 days agoChange DetectedThe value on the web page has changed from 'Acute Graft Versus Host Disease Myeloid Leukemia Acute Non Lymphoblastic Leukemia' to 'Myeloid Leukemia Acute Non Lymphoblastic Leukemia Acute Graft Versus Host Disease'. This change represents a reordering of the terms in the value.SummaryDifference0.3%
Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.